CIK 0001726445 · Laboratory Analytical Instruments (SIC 3826) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 16.6 M | 16.7 M | 15.5 M | |
| Net income (USD) | -93.0 M | -71.2 M | ||
| Diluted EPS (USD/shares) | -1.35 | -1.17 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | 3 | 3 | 2026-10-01 |
| 2026-09-18 | 8-K | 8-K items 5.02 | 2026-09-14 |
| 2026-08-19 | 4 | 4 | 2026-08-18 |
| 2026-08-11 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-11 | 8-K | 8-K items 2.02,9.01 | 2026-08-11 |
| 2026-07-31 | 8-K | 8-K items 5.07 | 2026-07-28 |
| 2026-07-31 | 8-K | 8-K items 8.01,9.01 | 2026-07-28 |
| 2026-07-30 | 4 | 4 | 2026-07-28 |
| 2026-07-30 | 4 | 4 | 2026-07-28 |
| 2026-07-30 | 4 | 4 | 2026-07-28 |
| 2026-07-30 | 4 | 4 | 2026-07-28 |
| 2026-07-30 | 4 | 4 | 2026-07-28 |
| 2026-07-30 | 4 | 4 | 2026-07-28 |
| 2026-07-28 | DFAN14A | DFAN14A | |
| 2026-07-24 | DFAN14A | DFAN14A | |
| 2026-07-22 | DEFA14A | DEFA14A | |
| 2026-07-22 | DFAN14A | DFAN14A | |
| 2026-07-20 | DEFA14A | DEFA14A | |
| 2026-07-20 | 8-K | 8-K items 8.01,9.01 | 2026-07-20 |
| 2026-07-20 | DEFA14A | DEFA14A | |
| 2026-07-20 | DEFA14A | DEFA14A | |
| 2026-07-17 | DFAN14A | DFAN14A | |
| 2026-07-14 | DEFA14A | DEFA14A | |
| 2026-07-14 | DEFA14A | DEFA14A | |
| 2026-07-10 | 4 | 4 | 2026-07-08 |
Forms on file (last 1,000): 4 137, 8-K 59, DEFA14A 29, SC 13G/A 24, 3 22, 10-Q 17, DFAN14A 15, SC 13G 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SEER (0.002 USD), /gw/filings/filings?ticker=SEER&form=8-K, /gw/filings/facts?ticker=SEER&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange